Module 1: Lifestyle Management

Nutrition
Alice H. Lichtenstein, D.Sc; Linda Shiue, MD

• Introduction to Nutrition & Cardiometabolic Health
• The Role of Nutrition in Cardiometabolic Health
• Assessment of nutritional status
• Nutritional therapy and components
• Guideline recommendations
• Culinary medicine & Practical Nutritional Approaches

Physical Activity
John M. Jakicic, PhD

• Introduction to Physical Activity & Cardiometabolic Health
• The Role of Physical Activity in Cardiometabolic Health
• Physical Activity Recommendations
• Types of physical activity and evidence for cardiometabolic health
• What type of PA is most beneficial based on underlying comorbidity (or comorbidities)

Smoking Cessation
Hilary A. Tindle, MD

• Introduction/overview–role of smoking in increasing cardiometabolic risk
• Assessment and screening of smoking status
• Behavioral interviewing
• Evidence-based strategies for smoking cessation (smoking cessation pharmacology, alternative tobacco products & more)

Sleep Medicine
Lee A. Surkin, MD; Christopher J. Lettieri, MD

• Introduction/overview: The impact of sleep disorders on cardiometabolic risk/disease
• Classification of sleep disorders
• Assessment, diagnosis, clinical manifestations and management of sleep disorders

Module 2: Obesity Management

Obesity as a Disease/Overview
Karli Burridge, PA-C, MMS, FOMA

• Introduction to Obesity: Epidemiology, Burden, Impact on Cardiometabolic Health
• Screening and Diagnosing Obesity
• How to Initiate Discussion with Patients & Communication Strategies
• Behavioral/motivational interviewing

Medical Management of Obesity
Donna H. Ryan, MD

• Review of current pharmacotherapy options: mechanisms of action, efficacy & safety
• Current guidelines

Metabolic Surgery
David E. Cummings, MD

• Efficacy and Safety
• Mechanisms of Action
• Role in Reducing Cardiometabolic Risk Beyond Obesity (Diabetes & CVD risk)
• Indications/Guidelines

MAFLD/MASH
Kenneth Cusi, MD; Christos S. Mantzoros, MD

• Epidemiology, Pathophysiology, Mechanisms
• Risk factors and Screening
• Diagnosis (from non-invasive to invasive)
• Therapeutic lifestyle management
• Current Pharmacologic management
• Emerging Pharmacotherapies & treatment targets

Module 3: Type 2 Diabetes

Diabetes Screening/Diagnosis
James R. Gavin III, MD, PhD

• Prevention & Delay of T2D/prediabetes
• Classification
• Diagnostic tests
• Prediabetes
• Comprehensive evaluation & assessment of comorbidities

Pharmacologic Approaches
Lauren C. Vincent, MD; Athena Philis-Tsimikas, MD

• Goals of therapy/glycemic targets
• Overview of efficacy and safety of different classes
• Overview of guidelines
• Stepwise approach to therapy
• Therapy according to comorbidities/ risk factors (HF, ASCVD, CKD)

Intensive/Advanced Glycemic Management
Irl B. Hirsch, MD; Anne L. Peters, MD

• Injectable therapies
• Insulin management (basal, basal-bolus, prandial–initiation & titration)
• Technology, insulin delivery systems, pumps, CGM & Closed Loop Systems

Module 4: Hypertension

Hypertension Definition/Screening/Diagnosis
Luke J. Laffin, MD

• Overview/Epidemiology/Burden
• Pathophysiology
• Definition, measurements & diagnosis (including out-of-office BP measurements)
• Risk factors and inducers of hypertension

Pharmacologic treatments
George L. Bakris, MD

• Lifestyle modification
• Pharmacological treatment & guidelines
• Adherence to antihypertensive treatment

Resistant Hypertension
George L. Bakris, MD

• Detection
• Evaluation
• Management

Module 5: Lipid Management

Introduction/Overview
Alan Chait, MD

• Pathophysiology & Vascular Biology
• Classification, Measurement and Metabolism of Lipids and Lipoproteins
• Cholesterol, lipoproteins, and ASCVD risk

Screening and Treatment of Hypercholesterolemia
Christie M. Ballantyne, MD; Maya Vadiveloo, PhD, RD; Pam R. Taub, MD

• ASCVD risk factors & risk enhancers/risk assessment
• Identification and diagnosis–testing & interpretation
• Treatment: Non-pharmacologic (lifestyle modifications)
• Pharmacologic treatment (from statin to non-statin therapies, efficacy & safety, guidelines; including statin intolerance

Dyslipidemia and/or Other Players
Robert H. Eckel, MD; Sotirios Tsimikas, MD

• Hypertriglyceridemia: Association or casative for ASCVD management
• HTG targets
• Review of HTG management strategies, from moderate to severe HTG
• Include HDL and HDL science/management (brief)
• Lipoprotein (a) science/evidence/management (include apheresis), emerging therapies

Module 6: Cardiovascular Disease

Cardiovascular Interfaces
Mikhail N. Kosiborod, MD

Advanced Non-Invasive Cardiac Imaging
Michael J. Blaha, MD

• ECG Interpretation
• CTA interpretation for cardiovascular risk estimation (CAC score as well as CCTA)
• Stress testing
• Echocardiography

Vascular Medicine and Thrombosis
Deepak L. Bhatt, MD; Marc P. Bonaca, MD

• PAD, CAD
• Epidemiology, burden
• Screening, risk factors, diagnosis
• Guidelines & management

Inpatient Cardiac Care and Consultations

• Preventive Cardiology
• Cardiac Rehabilitation
• ACS/Thrombosis
• Cardiac Catheterization
• Patient Cases

Arrhythmias
William H. Sauer, MD; Usha B. Tedrow, MD; Sunil Kapur, MD

• Atrial Fibrillation
• Other arrhythmias
• Risk factors, screening, diagnosis and management
• Stroke prevention management

Heart Failure
Alanna A. Morris, MD ; Ileana L. Piña, MD

• Overview, epidemiology, pathophysiology, burden
• Heart failure & cardiometabolic risk connections
• Screening and diagnostic approaches
• Management of Heart Failure (guidelines, spectrum of therapies/treatment table/efficacy and safety, newer therapies)

CVD Considerations in Women
Pam R. Taub, MD

CVD Considerations in Racial and Ethnic Minorities
Keith C. Ferdinand, MD

Module 7: Chronic Kidney Disase

CKD Spectrum
Rajiv Agarwal, MD, MS; George L. Bakris, MD

• Pathophysiology and Etiology
• Definitions and classification of CKD
• Screening, diagnosis, and prediction of CKD progression
• Screening of CKD stages 1-4

Module 8: Care Delivery Implementation 

Care Delivery Implementation
Mikhail N. Kosiborod, MD; Michael J. Blaha, MD; Melissa Magwire, RN, MSN, CDE

• Pathophysiology and Etiology
• Definitions and classification of CKD
• Screening, diagnosis, and prediction of CKD progression
• Screening of CKD stages 1-4